How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study.

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. — المؤلف: Birkeland, Kåre I — Diabetes, obesity & metabolism 20200907

المؤلف
Birkeland, Kåre I
النشر
Diabetes, obesity & metabolism 20200907
الوصف
968-974 p.
الموضوعات
Aged؛ Aged, 80 and over؛ Cardiovascular Diseases؛ Clinical Trials as Topic؛ Diabetes Mellitus, Type 2؛ Female؛ Germany؛ Humans